Package 67046-1459-3

{"route": ["ORAL"], "spl_id": "2d7daacc-a9ed-2f30-e063-6294a90a4a57", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["199147"], "spl_set_id": ["2d7db3b2-9b3c-3031-e063-6294a90a342c"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Coupler LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (67046-1459-3)", "package_ndc": "67046-1459-3", "marketing_start_date": "20250206"}], "brand_name": "Lamivudine", "product_id": "67046-1459_2d7daacc-a9ed-2f30-e063-6294a90a4a57", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "67046-1459", "generic_name": "Lamivudine", "labeler_name": "Coupler LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}], "application_number": "ANDA090457", "marketing_category": "ANDA", "marketing_start_date": "20250206", "listing_expiration_date": "20261231"}